Reply to: Clarification to provide further understanding of the conduct and design of TROPIC: A Phase 3 trial of cabazitaxel versus mitoxantrone in patients with metastatic castration-resistant prostate cancer

Gianpaolo Perletti
2016 Archivio Italiano di Urologia e Andrologia  
Not available.
doi:10.4081/aiua.2016.1.74 pmid:27072185 fatcat:puyexq63trfc5iqcoxzxowmlmq